Ledger.Open graph →
SEC Form D · filed April 17, 2025

Zero Point Five Therapeutics, Inc

Offering
$5.3M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Joseph Amprey Iii · Baltimore, MDExec · DirectorBen Auspitz · Baltimore, MDDirectorJodi Jahic · Baltimore, MDDirectorJoseph Amprey Iii · Baltimore, MDExec · DirectorJodi Jahic · Baltimore, MDDirectorBen Auspitz · Baltimore, MDDirectorAdCap Growth Partners, LLC · Pepper Pike, OHDirectorAd Cap Fund GP · Pepper Pike, OHExec · DirectorBryan Casey · Miami, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗